product summary
Loading...
company name :
Tocris Bioscience
product type :
chemical
product name :
6984/2
catalog :
6984/2
quantity :
2 mg
price :
179 USD
more info or order :
image
image 1 :

KIN001-266 CAS No. 915363-56-3 Tpl2 inhibitor
product information
master code :
6984
SKU :
6984/2
product name :
KIN001-266
unit size :
2 mg
description :
Potent and selective Tpl2 (MAP3K8) inhibitor
target :
MAP3K8/Tpl2/COT
category :
Small Molecules
purity :
98%
observed molecular weight :
539.44
url print :
?utm_source=labome&utm_medium=referral&utm_campaign=product&utm_term=smallmolecules
details of functionality :
KIN001-266 is a potent and selective Tpl2 (Cot; MAP3K8) inhibitor (IC50 = 1.6 nM). It exhibits 6875-fold selectivity over EGFR. In vivo , it inhibits TNF- production in a LPS-stimulated rat inflammation model. KIN001-266 is orally bioavailable.
top caption :
Potent and selective Tpl2 (MAP3K8) inhibitor
extended description :
Potent and selective Tpl2 (MAP3K8) inhibitor
chemical name text :
8-Chloro-4-[(3-chloro-4-fluorophenyl)amino]-6-[[[1-(1-ethyl-4-piperidinyl)-1H-1,2,3-triazol-4-yl]methyl]amino]-3-quinolinecarbonitrile
formula :
C26H25Cl2FN8
formula text :
C26H25Cl2FN8
cas num :
915363-56-3
USD :
179 USD
product details :
Potent and selective Tpl2 (MAP3K8) inhibitor
alt names :
Cachetin, Cancer Osaka thyroid oncogene, c-COT, COT, cot (cancer Osaka thyroid) oncogene, COTMEKK8, DIF, EC 2.7.11.25, EST, ESTF, ESTFLJ10486, Ewing sarcoma transformant, MAP3K8, mitogen-activated protein kinase kinase kinase 8, Proto-oncogene c-Cot, proto-oncogene serine/threoine protein kinase, Serine/threonine-protein kinase cot, TNF, TNFA, TNF-A, TNFalpha, TNFG1F, TNFSF1A, TNFSF2, Tpl-2, TPL2, Tumor progression locus 2, tumor progression locus-2
storage :
Store at -20░C
more info or order :
company information

Tocris Bioscience
The Watkins Building
Atlantic Road
Avonmouth, Bristol
BS11 9QD
Atlantic Road
Avonmouth, Bristol
BS11 9QD
info@bio-techne.com
https://www.tocris.com800-343-7475
headquarters: UK
browse more products
questions and comments